Presentation + Paper
12 March 2024 NeoglyQCL-based NI-CGM medical device
Author Affiliations +
Abstract
Introducing NEOGLY™, a novel body-worn QCL-based non-invasive continuous glucose monitoring device (NI-CGM). Developed under ISO 13485 regulation, it shows relevant glycemia predictions based on mid-infrared photoacoustic spectroscopy as well as AI-based algorithms fed by a digital twin that covers the entire detection chain including device modeling and human skin properties.
Conference Presentation
(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.
Jean-Guillaume Coutard, Rolf Aidam, Florent Bernet, Romain Blanc, Morgane Boucher-Doigneau, Daphnée Jobert, Thibault Le Roux-Mallouf, Grégoire Mathieu, Alexandra Metz, Cyrielle Monpeurt, Sophie Moulin, Freddy Runget, Stéphane Triomphe, Kevin Jourde, Sebastien Barnola, Olivier Lartigue, Marion Volpert, Toufiq Bria, and Hélène Lefebvre "NeoglyQCL-based NI-CGM medical device", Proc. SPIE 12838, Biophotonics in Exercise Science, Sports Medicine, Health Monitoring Technologies, and Wearables V, 1283802 (12 March 2024); https://doi.org/10.1117/12.2692660
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Skin

Photoacoustic spectroscopy

Glucose

Quantum cascade lasers

Sensors

Design

Algorithm development

Back to Top